With significant upside potential, Sanofi (NASDAQ:SNY) secures a spot on our list of the 12 Best Widow and Orphan Stocks to ...

Remission of prediabetes can occur even without weight loss, protecting against type 2 diabetes in up to 22% of individuals.

OPINION - In my experience, waiting for affordable medications is a matter of life and death. Each day that goes by without ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa ...

Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 ...

Sanofi is expanding its U.S. insulin savings program to include all U.S. patients who have a valid prescription, regardless of their insurance status. Sanofi on Friday said the program will offer a 30 ...

Endocrinologists have debunked widespread myths surrounding the use of insulin in the management of diabetes, describing insulin injection as a life-saving treatment essential for controlling blood ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

1 Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, United States 2 Oden Institute for Computational Engineering and Sciences, The University of Texas ...